CLIPAD

Meeting Exclusives

01/29/2020

(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who...

(Leipzig, Germany) January 29,...

01/29/2020

Vascular Disease Management

Meeting Exclusives

Lutonix BTK Trial 12-Month Data Released

01/29/2020

(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the...

(Leipzig, Germany) January 29,...

01/29/2020

Vascular Disease Management

News

BD Announces Long-Term Safety Data for Below-the-Knee Drug-Coated Balloon

01/29/2020

Vascular Disease Management

Meeting Exclusives

One-Year Results From COMPARE Trial Presented at LINC

01/28/2020

One-year results from the COMPARE trial were presented by Sabine Steiner, MD, on the first morning of LINC, shedding new light on the impact of high- vs low-dose paclitaxel dosing in drug-eluting balloon (DCB) treatment of femoropopliteal...

One-year results from the...

01/28/2020

Vascular Disease Management

Meeting Exclusives

Pedal-Plantar Loop Techniques: Lessons From a Maestro

01/28/2020

Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).

Below-the-ankle...

01/28/2020

Vascular Disease Management

Meeting Exclusives

Independent Analysis of Lutonix DCB Data Reveals No Plausible Link Between Paclitaxel and Mortality

01/28/2020

Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.

Kenneth Ouriel, MD, presented...

01/28/2020

Vascular Disease Management

News

Four-Year Data From ILLUMENATE Pivotal Trial Reaffirms Safety Profile of Philips Stellarex Low-Dose Drug-Coated Balloon

01/27/2020

With mortality rates similar to standard of care through four years with excellent rate of follow-up compliance, Philips Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate sustained treatment effect and high safety...

With mortality rates similar to...

01/27/2020

Vascular Disease Management

TOBA II BTK 6-Month Pivotal Data: Tack Endovascular System Successfully Meets Primary and Secondary Safety, Efficacy Endpoints

01/24/2020

George Adams, MD, MHS, MBA, presented six-month data from the Tack Optimized Balloon Angioplasty II (TOBA II) Below the Knee (BTK) trial Friday morning at the International Symposium on Endovascular Therapy (ISET).

George Adams, MD, MHS, MBA,...

01/24/2020

Vascular Disease Management

Experts Share Practical Tips for Treating Complex CLI/PAD

01/24/2020

In an afternoon session at the International Symposium on Endovascular Therapy, presenters reviewed practical tips and techniques for treating patients with complex critical limb ischemia (CLI) and peripheral arterial disease (PAD).

In an afternoon session at the...

01/24/2020

Vascular Disease Management

Meeting Exclusives

Comparative Outcomes of Supera vs Bare Nitinol Stents in FemPop Disease: Insights From the XLPAD Registry

01/24/2020

Hollywood, FL (January 24, 2020) – The Supera stent (Abbott Vascular) is a “fundamentally different design”, said Bret Wiechmann, MD, of Vascular & Interventional Physicians in Gainesville, Florida, in his Friday morning presentation on the...

Hollywood, FL (January 24, 2020)...

01/24/2020

Vascular Disease Management